News
The 2025 ASCO Annual Meeting is The Place to Be—a global gathering where oncology professionals connect, collaborate, and inspire. Known for advancing the field, this must-attend event offers an ...
For reference, please review the following policies and guidelines. As you prepare your submission to the Meeting, please make note of the following author and sponsorship eligibility criteria: ...
Learn more about abstract submission, policies, and guidelines for faculty and presenters.
The 2025 ASCO Annual Meeting Abstract Submitter is closed. For information regarding abstract submission, including abstract categories, guidelines, and policies, please review the pages linked below.
Explore resources for getting to Chicago and navigating the ASCO Annual Meeting online and in-person.
Start planning before you arrive at McCormick Place. View the information below so you know where to go for all of your needs while you’re at the Meeting, including onsite childcare and accessibility ...
Online registrations are processed securely and confirmed immediately by email. Below you will find information related to registration fees, special rate categories, registration changes, and ...
The deadline for early registration and hotel reservations is April 23, 2025, at 11:59 PM ET. Below you will find registration rates and details, hotel information, and links to book your hotel and ...
Ancillary events are functions held adjacent to the ASCO Annual Meeting, including, but not limited to, advisory board meetings, educational events, focus groups, investigator meetings, and social ...
ASCO understands the importance of making connections, sharing ideas, and establishing the foundation for future collaborations, and we're so excited to give you the chance to connect onsite. At ...
The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: On April 11, 2025, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results